FIGURE 9.

Comparison of liver and Kidney function biomarker levels in the four rat groups. Group I (Control): Normal water consumption. Group II (Met): addition of Metribuzin (110 mg/kg body weight/day) in drinking water for 21 days. Group III (8/Ag₂O NPs0.062 mg/kg): Met exposure (as in Group II) followed by Ag/Ag₂O NPs (dose 0.0625 mg/kg, body weight/day by intraperitoneal injection) for 21 days. Group IV (Met + Ag/Ag₂O NPs0.125 mg/kg): Met exposure (as in Group II) followed by Ag/Ag₂O NPs (dose 0.125 mg/kg, body weight/day by intraperitoneal injection) for 21 days. (A): (Serum Urea g/L), (B): Serum Creatinine mg/L, (C): Serum Uric Acid mg/L (D): ASAT U/mL, (E): ALAT U/mL. *p < 0.05, **p < 0.01: significantly different from Group I, a p < 0.05, b p < 0.01: significantly different from Group II.